Seretide for Bronchial Asthma: A Clinical Study of 55 Cases
Yao Yang-wei
Abstract
Yao Yang-wei
Abstract
Objective To investigate the effect of Seretide on the lung function in 55 cases of bronchial asthma and clinical efficacy. Methods We divided 110 cases of bronchial asthma treated in our hospital randomly into control group(n=55) and treatment group(n=55). The control group received theophylline sustained-release tablets besides routine treatment, and the treatment group received Seretide besides routine treatment.The lung function and clinical efficacy were evaluated in the two groups after 2 month treatment. Results There was a significant difference in FEV1、FVC and PEF after 2 month treatment between the two groups(P0.05). The total efficacy of the treatment group was 94.55% and that of the control group was 81.82%,with a significant difference(P0.05) between the two groups. Conclusion Seretide can obviously improve the lung function of the patients with bronchial asthma ,with good clinical efficacy.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the effect of Seretide on the lung function in 55 cases of bronchial asthma and clinical efficacy. Methods We divided 110 cases of bronchial asthma treated in our hospital randomly into control group(n=55) and treatment group(n=55). The control group received theophylline sustained-release tablets besides routine treatment, and the treatment group received Seretide besides routine treatment.The lung function and clinical efficacy were evaluated in the two groups after 2 month treatment. Results There was a significant difference in FEV1、FVC and PEF after 2 month treatment between the two groups(P0.05). The total efficacy of the treatment group was 94.55% and that of the control group was 81.82%,with a significant difference(P0.05) between the two groups. Conclusion Seretide can obviously improve the lung function of the patients with bronchial asthma ,with good clinical efficacy.
Key concepts: Medicine, Asthma, Clinical efficacy, Lung function, Significant difference, Treatment and control groups, Pulmonary function testing, Conventional treatment